ATE67675T1 - Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. - Google Patents

Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.

Info

Publication number
ATE67675T1
ATE67675T1 AT87903945T AT87903945T ATE67675T1 AT E67675 T1 ATE67675 T1 AT E67675T1 AT 87903945 T AT87903945 T AT 87903945T AT 87903945 T AT87903945 T AT 87903945T AT E67675 T1 ATE67675 T1 AT E67675T1
Authority
AT
Austria
Prior art keywords
diseases
treatment
inflammatory
combination
gamma interferons
Prior art date
Application number
AT87903945T
Other languages
English (en)
Inventor
Steven D Reich
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25365733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE67675(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of ATE67675T1 publication Critical patent/ATE67675T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87903945T 1986-06-17 1987-06-01 Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. ATE67675T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87540186A 1986-06-17 1986-06-17
EP87903945A EP0311616B1 (de) 1986-06-17 1987-06-01 Kombination von gammainterferonen und antientzündungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten
PCT/US1987/001228 WO1987007842A1 (en) 1986-06-17 1987-06-01 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases

Publications (1)

Publication Number Publication Date
ATE67675T1 true ATE67675T1 (de) 1991-10-15

Family

ID=25365733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87903945T ATE67675T1 (de) 1986-06-17 1987-06-01 Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.

Country Status (5)

Country Link
EP (1) EP0311616B1 (de)
JP (1) JPH01502980A (de)
AT (1) ATE67675T1 (de)
DE (1) DE3773387D1 (de)
WO (1) WO1987007842A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200177A (en) * 1989-12-01 1993-04-06 The Children's Medical Center Corporation Treatment of atopic disorders with gamma-interferon
EP0502997B1 (de) * 1989-12-01 1995-05-03 Children's Medical Center Corporation Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma
ES2137981T3 (es) * 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
US5266312A (en) * 1992-01-07 1993-11-30 National Jewis Center For Immunology And Respiratory Medicine Method for treating a steroid resistant condition via administration of gamma interferon
GB2293323A (en) * 1994-09-12 1996-03-27 Orion Yhtymae Oy Antibiotics and bismuth salts for treating bacterial infections
EP0783303B1 (de) * 1994-09-16 2002-11-27 President And Fellows Of Harvard College Verwendung von aromatischen halogenverbindungen zur behandlung der zellproliferation in säugetieren
CA2209016A1 (en) * 1994-12-28 1996-07-04 Teikoku Hormone Mfg. Co., Ltd. Pharmaceutics for mucosal administration
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
EP0795332B1 (de) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Medizinische Verwendung von Gamma-Interferon im interstitiellen Lungenerkrankungen
US6299871B1 (en) * 1998-07-24 2001-10-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases
WO2001034180A2 (en) * 1999-11-10 2001-05-17 Mondobiotech Sa Interferon gamma for the treatment of asthma
GB0518558D0 (en) 2005-09-12 2005-10-19 Givaudan Sa Improvements in or related to organic compounds
FR2958849A1 (fr) * 2010-04-14 2011-10-21 Boiron Medicament homeopathique a activite anti-cancereuse

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252797A (en) * 1979-07-19 1981-02-24 Walter Rosenthal Corticosteroid calcium compositions and treatment of rheumatic diseases therewith
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
US4390545A (en) * 1981-11-19 1983-06-28 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof

Also Published As

Publication number Publication date
JPH01502980A (ja) 1989-10-12
EP0311616A4 (de) 1989-05-23
WO1987007842A1 (en) 1987-12-30
EP0311616B1 (de) 1991-09-25
EP0311616A1 (de) 1989-04-19
DE3773387D1 (de) 1991-10-31

Similar Documents

Publication Publication Date Title
ATE277612T1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE67675T1 (de) Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
DK623186D0 (da) Polypeptid med vaevsplasminogen-aktivator-virkning
ATE179458T1 (de) Verwendung von papillomavirusprotein l2 zur therapeutischen behandlung von durch papillomavirus hervorgerufenen tumoren oder oder anderen krankhaften veränderungen
PT705100E (pt) Guanidinas substituidas terapeuticas
DK467487A (da) Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis
DE69813839D1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
DE69230798D1 (de) Rekombinante immuntoxine
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
NO922456D0 (no) Bcrf1-proteiner som inhibitorer av interferon-gamma
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE3771584D1 (de) Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE3674619D1 (de) Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked